Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, et al; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracra- nial arterial stenosis. Circulation. 2006;113:555 563. doi: 10.1161/ 361. EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. results of an international randomized trial. N Engl J Med. 1985;313:1191 1200. doi: 10.1056/ 362. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial oc- clusive disease: a large worldwide burden but a relatively neglected frontier. 363. Amin-Hanjani S, Pandey DK, Rose-Finnell L, Du X, Richardson D, Thulborn KR, Elkind MS, Zipfel GJ, Liebeskind DS, Silver FL, et al; Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke Study Group. Effect of hemodynamics on stroke risk in symptomatic atheroscle- rotic vertebrobasilar occlusive disease. JAMA Neurol. 2016;73:178 185. 364. L pez-Cancio E, Matheus MG, Romano JG, Liebeskind DS, Prabhakaran S, Turan TN, Cotsonis GA, Lynn MJ, Rumboldt Z, Chimowitz MI. Infarct patterns, collaterals and likely causative mechanisms of stroke in symp- tomatic intracranial atherosclerosis. Cerebrovasc Dis. 2014;37:417 422. 365. Johnston SC, Elm JJ, Easton JD, Farrant M, Barsan WG, Kim AS, Lindblad AS, Palesch YY, Zurita KG, Albers GW, et al; POINT and Neurological Emergencies Treatment Trials Network Investigators. Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke. Circulation. 2019;140:658 664. doi: 366. US Food and Drug Administration. Use of the Stryker Wingspan stent sys- tem outside of approved indications leads to an increased risk of stroke or death: FDA Safety Communication. 2019. Accessed December 3, 2020. https://www.fda.gov/medical-devices/medical-device-safety/use-stryker- wingspan-stent-system-outside-approved-indications-leads-increased- risk-stroke-or-death CLINICAL STATEMENTS AND GUIDELINES Kleindorfer 367. US Food and Drug Administration. 